These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 6123478

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A, Tsvetkova V, Krŭstev Z, Kostova N, Lukanov L.
    Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
    [No Abstract] [Full Text] [Related]

  • 6. [Experiments with a new drug in chronic liver diseases, especially alcohol-induced].
    Bel A, Chambon A.
    Minerva Dietol Gastroenterol; 1977; 23(3):243-8. PubMed ID: 372846
    [No Abstract] [Full Text] [Related]

  • 7. (+)-Cyanidanol-3 for alcoholic liver disease: results of a six-month clinical trial.
    World MJ, Aps EJ, Shaw GK, Thomson AD.
    Alcohol Alcohol; 1984; 19(1):23-9. PubMed ID: 6149758
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cianidanol therapy for HBe-antigen-positive chronic hepatitis: a multicentre, double-blind study.
    Suzuki H, Yamamoto S, Hirayama C, Takino T, Fujisawa K, Oda T.
    Liver; 1986 Feb; 6(1):35-44. PubMed ID: 3520204
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [A study of the effects of procyanidol oligomers on capillary resistance in hypertension and in certain nephropathies (author's transl)].
    Lagrue G, Olivier-Martin F, Grillot A.
    Sem Hop; 1986 Feb; 57(33-36):1399-401. PubMed ID: 6270799
    [Abstract] [Full Text] [Related]

  • 12. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
    Halmy L, Dávid K, Nagy I, Stotz G, Kelemen JT.
    Acta Physiol Hung; 1984 Feb; 64(3-4):461-70. PubMed ID: 6152370
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of Endotelon in postoperative edema. Results of a double-blind study versus placebo in 32 female patients].
    Baruch J.
    Ann Chir Plast Esthet; 1984 Feb; 29(4):393-5. PubMed ID: 6084452
    [No Abstract] [Full Text] [Related]

  • 16. [The treatment of acute viral hepatitis with (+)-cyanidanol-3].
    Pelloni S, Berthet P, Blum AL, Doelle W, Goebell H, Kortüm K, Peter P, Poulsen H, Strohmeyer G, Tygstrup N.
    Schweiz Med Wochenschr; 1977 Dec 10; 107(49):1859-61. PubMed ID: 337476
    [No Abstract] [Full Text] [Related]

  • 17. (+)-cyanidanol-3.
    Lancet; 1982 Mar 06; 1(8271):549. PubMed ID: 6120400
    [No Abstract] [Full Text] [Related]

  • 18. [Enzymologic evaluation of the effectiveness of the hepatotropic drug catergen in chronic liver diseases].
    Tamarkina AD, Neverov IV, Turitsyna IG, Dement'eva ES, Krylova NI.
    Sov Med; 1985 Mar 06; (12):26-30. PubMed ID: 4095626
    [No Abstract] [Full Text] [Related]

  • 19. [Influence of (+)-cyanidanol-3 on the course of acute viral hepatitis (author's transl)].
    Vido I, Schmidt FW, Müller R, Ranft U, Wildhirt E, Holzer E, Wallnöfer H, Korb G.
    Dtsch Med Wochenschr; 1980 Mar 07; 105(10):330-2. PubMed ID: 6153953
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.